LIFR Antikörper (AA 692-833)
Kurzübersicht für LIFR Antikörper (AA 692-833) (ABIN7621575)
Target
Alle LIFR Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 692-833
-
Verwendungszweck
- Leukemia Inhibitory Factor Receptor (LIFR) Polyclonal Antibody
-
Sequenz
- Arg692~Ser833
-
Produktmerkmale
- The Leukemia Inhibitory Factor Receptor (LIFR) Polyclonal Antibody (Species: Human) has been validated for the following applications: WB, IHC, ICC, IP.
-
Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.5 mg/mL
-
Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- 2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- LIFR (Leukemia Inhibitory Factor Receptor alpha (LIFR))
-
Andere Bezeichnung
- LIFR
-
Gen-ID
- 3977
-
UniProt
- P42702
-
Pathways
- JAK-STAT Signalweg, Growth Factor Binding
Target
-